FDA’s Moore on Where QbD’s Been, and Where It’s Going

July 1, 2009
6445 views
URL
Embed
Share

Please describe the reason for abuse:



Description:
FDA CDER’s Christine Moore, PhD, acting deputy director of the Office of New Drug Quality Assessment, explains how her office is leading the... » More